Results overview: Found 36 records in 0.02 seconds.
Articles, 32 records found
Research literature, 4 records found
Articles 32 records found  1 - 10nextend  jump to record:
1.
15 p, 3.7 MB Large T cell clones expressing immune checkpoints increase during multiple myeloma evolution and predict treatment resistance / Botta, Cirino (Clínica Universidad de Navarra) ; Perez, Cristina (Clínica Universidad de Navarra) ; Larrayoz, Marta (Clínica Universidad de Navarra) ; Puig, Noemí (Hospital Universitario de Salamanca) ; Cedena, María Teresa (Hospital Universitario 12 de Octubre) ; Termini, Rosalinda (Clínica Universidad de Navarra) ; Goicoechea, Ibai (Clínica Universidad de Navarra) ; Rodriguez, Sara (Clínica Universidad de Navarra) ; Zabaleta, Aintzane (Clínica Universidad de Navarra) ; Lopez, Aitziber (Clínica Universidad de Navarra) ; Sarvide, Sarai (Clínica Universidad de Navarra) ; Blanco, Laura (Clínica Universidad de Navarra) ; Papetti, Daniele Marco (Department of Informatics. University of Milano-Bicocca) ; Nobile, M.S. (Biostatistics and Bioimaging Centre-B4) ; Besozzi, Daniela (Biostatistics and Bioimaging Centre-B4) ; Gentile, Massimo (Department of Oncohematology. "Annunziata" Hospital) ; Correale, Pierpaolo (Great Metropolitan Hospital "Riuniti" of Reggio Calabria) ; Siragusa, Sergio (Department of Health Promotion. University of Palermo) ; Oriol, Albert (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; González-Garcia, Maria Esther (Hospital Universitario de Cabueñes (Gijón)) ; Sureda, Anna (Institut d'Investigació Biomèdica de Bellvitge) ; de Arriba, Felipe (Instituto Murciano de Investigación Biosanitaria) ; Ríos-Tamayo, Rafael (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ; Moraleda, José María (Instituto Murciano de Investigación Biosanitaria) ; Gironella, Mercedes (Hospital Universitari Vall d'Hebron) ; Hernández, Miguel T. (Hospital Universitario de Canarias (Illes Canàries)) ; Bargay, Joan (Hospital Universitari Son Llàtzer (Illes Balears)) ; Palomera, Luís (Hospital Clínico Universitario "Lozano Blesa" de Zaragoza) ; Pérez-Montaña, Albert (Hospital Universitari Son Espases (Illes Balears)) ; Goldschmidt, Hartmut (Department of Internal Medicine V. University of Heidelberg) ; Avet-Loiseau, Hervé (IUC-T Oncopole) ; Roccaro, Aldo (Department of Hematology. ASST Spedali Civili di Brescia) ; Orfao, Alberto (Universidad de Salamanca. Departament de Medicina) ; Martinez-Lopez, Joaquín (Hospital Universitario 12 de Octubre) ; Rosiñol, Laura (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Lahuerta, J. J (Hospital Universitario 12 de Octubre) ; Bladé Creixenti, Juan (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Mateos, M. V (Hospital Universitario de SalamancaBiomedica de Salamanca (IBSAL). Centro de Investigación del Cancer (IBMCC-USAL. CSIC)) ; San-Miguel, J (Clínica Universidad de Navarra) ; Martinez Climent, Juan-José (Clínica Universidad de Navarra) ; Paiva, Bruno (Clínica Universidad de Navarra)
Tumor recognition by T cells is essential for antitumor immunity. A comprehensive characterization of T cell diversity may be key to understanding the success of immunomodulatory drugs and failure of PD-1 blockade in tumors such as multiple myeloma (MM). [...]
2023 - 10.1038/s41467-023-41562-6
Nature communications, Vol. 14 Núm. 1 (december 2023) , p. 5825  
2.
15 p, 2.7 MB ALPL-1 is a target for chimeric antigen receptor therapy in osteosarcoma / Mensali, Nadia (Department of Cellular Therapy. Oslo University Hospital) ; Köksal, Hakan (Oslo University Hospital) ; Joaquina, Sandy (Oslo University Hospital) ; Wernhoff, Patrick (Oslo University Hospital) ; Casey, Nicholas P. (Oslo University Hospital) ; Romecín, Paola Alejandra (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Panisello, Carla (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Rodríguez, René (Instituto de Salud Carlos III) ; Vimeux, Lene (Université de Paris) ; Juzeniene, Asta (Oslo University Hospital) ; Myhre, Marit R. (Oslo University Hospital) ; Fåne, Anne (Oslo University Hospital) ; Castilla-Ramirez, Carolina (Virgen del Rocio University Hospital) ; Maggadottir, Solrun Melkork (Oslo University Hospital) ; Duru, Adil Doganay (Nova Southeastern University) ; Georgoudaki, Anna-Maria (Department of Oncology-Pathology. Karolinska Institutet) ; Grad, Iwona (Oslo University Hospital) ; Maturana, Andrés Daniel (Nagoya University) ; Gaudernack, Gustav (Department of Cancer Immunology. Oslo University Hospital) ; Kvalheim, Gunnar (Department of Cellular Therapy. Oslo University Hospital) ; Carcaboso, Angel M. (Institut de Recerca Sant Joan de Déu) ; De Álava, Enrique (Universidad de Sevilla) ; Donnadieu, Emma (Université de Paris) ; Bruland, Øyvind S (University of Oslo) ; Menendez, Pablo (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Inderberg, Else Marit (Oslo University Hospital) ; Wälchli, Sébastien (Oslo University Hospital)
Osteosarcoma (OS) remains a dismal malignancy in children and young adults, with poor outcome for metastatic and recurrent disease. Immunotherapies in OS are not as promising as in some other cancer types due to intra-tumor heterogeneity and considerable off-target expression of the potentially targetable proteins. [...]
2023 - 10.1038/s41467-023-39097-x
Nature communications, Vol. 14 Núm. 1 (december 2023) , p. 3375  
3.
21 p, 4.3 MB The Robustness of Cellular Immunity Determines the Fate of SARS-CoV-2 Infection / Moga, Esther (Institut d'Investigació Biomèdica Sant Pau) ; Lynton-Pons, Elionor (Institut d'Investigació Biomèdica Sant Pau) ; Domingo, Pere (Institut d'Investigació Biomèdica Sant Pau) ; Universitat Autònoma de Barcelona
Two years after the appearance of the SARS-CoV-2 virus, the causal agent of the current global pandemic, it is time to analyze the evolution of the immune protection that infection and vaccination provide. [...]
2022 - 10.3389/fimmu.2022.904686
Frontiers in immunology, Vol. 13 (june 2022) , p. 904686  
4.
16 p, 860.7 KB Activation of the Monocyte/Macrophage System and Abnormal Blood Levels of Lymphocyte Subpopulations in Individuals with Autism Spectrum Disorder : A Systematic Review and Meta-Analysis / Arteaga-Henríquez, Gara (Hospital Universitari Vall d'Hebron) ; Lugo-Marín, Jorge (Hospital Universitari Vall d'Hebron) ; Gisbert-Gustemps, Laura (Hospital Universitari Vall d'Hebron) ; Setién-Ramos, Imanol (Hospital Universitari Vall d'Hebron) ; Martínez Gallo, Mónica (Hospital Universitari Vall d'Hebron) ; Pujol-Borrell, Ricardo (Hospital Universitari Vall d'Hebron) ; Ramos-Quiroga, Josep Antoni (Hospital Universitari Vall d'Hebron) ; Universitat Autònoma de Barcelona
Autism spectrum disorder (ASD) is a neurodevelopmental condition with a so far unknown etiology. Increasing evidence suggests that a state of systemic low-grade inflammation may be involved in the pathophysiology of this condition. [...]
2022 - 10.3390/ijms232214329
International journal of molecular sciences, Vol. 23 (november 2022)  
5.
19 p, 2.3 MB B Cells in Breast Cancer Pathology / Li, Mengyuan (King's College London) ; Quintana, Angela (Vall d'Hebron Institut d'Oncologia) ; Alberts, Elena (The Francis Crick Institute) ; Hung, Miu Shing (King's College London) ; Boulat, Victoire (King's College London) ; Martí, Mercè (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ; Grigoriadis, Anita (School of Cancer and Pharmaceutical Sciences) ; Universitat Autònoma de Barcelona. Institut de Biotecnologia i de Biomedicina "Vicent Villar Palasí"
B cells in the tumour microenvironment and lymph nodes have affirmed their role in breast cancer pathology. Multiplex imaging, single cell, and spatial transcriptomics of cancer patients' breast carcinomas and lymph nodes have illustrated the diversity and spatial context of B cells in this disease. [...]
2023 - 10.3390/cancers15051517
Cancers, Vol. 15, Issue 5 (February 2023) , art. 1517  
6.
10 p, 554.8 KB Biological and Molecular Factors Predicting Response to Adoptive Cell Therapies in Cancer / Ferrer, Gerardo (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Álvarez-Errico, Damiana (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Esteller, M (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras)
Adoptive cell therapy (ACT) constitutes a major breakthrough in cancer management that has expanded in the past years due to impressive results showing durable and even curative responses for some patients with hematological malignancies. [...]
2022 - 10.1093/jnci/djac088
Journal of the National Cancer Institute, Vol. 114 Núm. 7 (january 2022) , p. 930-939  
7.
18 p, 9.8 MB Single-cell Atlas of common variable immunodeficiency shows germinal center-associated epigenetic dysregulation in B-cell responses / Rodríguez-Ubreva, J. (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Arutyunyan, A. (University of Cambridge) ; Bonder, M.J. (German Cancer Research Center) ; Del Pino-Molina, L. (Instituto de Investigación Sanitaria del Hospital Universitario La Paz) ; Clark, S.J. (Babraham Institute) ; de la Calle-Fabregat, Carlos (Institut d'Investigació Biomèdica de Bellvitge) ; Garcia-Alonso, L. (CeWellcome Sanger Institute) ; Handfield, L.F. (Wellcome Trust Sanger Institute (Regne Unit)) ; Ciudad, Laura (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Andrés-León, Eduardo (Instituto de Parasitología y Biomedicina "López-Neyra") ; Krueger, F. (Babraham Institute) ; Català-Moll, Francesc (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Rodríguez-Cortez, V.C. (Institut d'Investigació Biomèdica de Bellvitge) ; Polanski, K. (Wellcome Trust Sanger Institute (Regne Unit)) ; Mamanova, L. (Wellcome Trust Sanger Institute (Regne Unit)) ; van Dongen, S. (Wellcome Trust Sanger Institute (Regne Unit)) ; Kiselev, V.Y. (Wellcome Trust Sanger Institute (Regne Unit)) ; Martínez-Saavedra, M.T. (Hospital Universitario de Gran Canaria Dr. Negrín) ; Heyn, Holger (Universitat Pompeu Fabra) ; Martín, Javier (Instituto de Parasitología y Biomedicina "López-Neyra") ; Warnatz, K. (University of Freiburg) ; López-Granados, E. (Instituto de Investigación Sanitaria del Hospital Universitario La Paz) ; Rodríguez-Gallego, C. (University Fernando Pessoa) ; Stegle, O. (Wellcome Trust Sanger Institute (Regne Unit)) ; Kelsey, G. (Babraham Institute) ; Vento Tormo, Roser (University of Cambridge) ; Ballestar, Esteban (East China Normal University) ; Universitat Autònoma de Barcelona
Common variable immunodeficiency (CVID), the most prevalent symptomatic primary immunodeficiency, displays impaired terminal B-cell differentiation and defective antibody responses. Incomplete genetic penetrance and ample phenotypic expressivity in CVID suggest the participation of additional pathogenic mechanisms. [...]
2022 - 10.1038/s41467-022-29450-x
Nature communications, Vol. 13 Núm. 1 (december 2022) , p. 1779  
8.
14 p, 2.8 MB Endothelial damage and dysfunction in acute graft-versus-host disease / Cordes, Steffen (Charité - Universitätsmedizin Berlin) ; Mokhtari, Zeinab (Department of Medicine II. Würzburg University Hospital. Interdisciplinary Center for Clinical Research (IZKF). Laboratory for Experimental Stem Cell Transplantation) ; Bartosova, Maria (Pediatric Nephrology. Center for Pediatric and Adolescent Medicine. University Hospital Heidelberg) ; Mertlitz, Sarah (Charité - Universitätsmedizin Berlin) ; Riesner, Katarina (Charité - Universitätsmedizin Berlin) ; Shi, Yu (Charité - Universitätsmedizin Berlin) ; Mengwasser, Jörg (Department of Surgery. Charité Universitätsmedizin Berlin) ; Kalupa, Martina (Charité - Universitätsmedizin Berlin) ; McGeary, Aleixandria (Charité - Universitätsmedizin Berlin) ; Schleifenbaum, Johanna (Institute of Vegetative. Charité Universitätsmedizin Berlin) ; Schrezenmeier, Jens (Charité - Universitätsmedizin Berlin) ; Bullinger, Lars (Charité - Universitätsmedizin Berlin) ; Diaz-Ricart, Maribel (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Palomo, Marta (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Carreras, Enric (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Beutel, Gernot (Hannover Medical School) ; Schmitt, Claus Peter (Center for Child and Adolescent Medicine (Heidelberg, Alemanya)) ; Beilhack, Andreas (Würzburg University Hospital) ; Penack, Olaf (Charité - Universitätsmedizin Berlin) ; Universitat Autònoma de Barcelona
Clinical studies have suggested a potential involvement of endothelial dysfunction and damage in the development and severity of acute graft-versus-host disease (aGvHD). Accordingly, we found an increased percentage of apoptotic caspase 3 positive blood vessels in duodenal and colonic mucosa biopsies of patients with severe aGvHD. [...]
2021 - 10.3324/haematol.2020.253716
Haematologica, Vol. 106 Núm. 8 (august 2021) , p. 2147-2160  
9.
18 p, 1.5 MB Epigenetic control of infant b cell precursor acute lymphoblastic leukemia / de Barrios, Oriol (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Parra, Maribel (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras)
B-cell precursor acute lymphoblastic leukemia (BCP-ALL) is a highly aggressive malig-nancy, with poorer prognosis in infants than in adults. A genetic signature has been associated with this outcome but, remarkably, leukemogenesis is commonly triggered by genetic alterations of embryonic origin that involve the deregulation of chromatin remodelers. [...]
2021 - 10.3390/ijms22063127
International journal of molecular sciences, Vol. 22 Núm. 6 (march 2021) , p. 1-18  
10.
36 p, 800.8 KB Establishment and validation of surface model for biodosimetry based on γ-H2AX foci detection / López Vásquez, Juan Sebastián (Universitat Autònoma de Barcelona. Departament de Biologia Animal, de Biologia Vegetal i d'Ecologia) ; Pujol Canadell, Mònica (Universitat Autònoma de Barcelona. Departament de Biologia Animal, de Biologia Vegetal i d'Ecologia) ; Puig, Pedro (Universitat Autònoma de Barcelona. Departament de Matemàtiques) ; Ribas, Montserrat (Institut d'Investigació Biomèdica Sant Pau) ; Carrasco de Fez, Pablo (Institut d'Investigació Biomèdica Sant Pau) ; Armengol Rosell, Gemma (Universitat Autònoma de Barcelona. Departament de Biologia Animal, de Biologia Vegetal i d'Ecologia) ; Barquinero, Joan Francesc (Universitat Autònoma de Barcelona. Departament de Biologia Animal, de Biologia Vegetal i d'Ecologia)
Introduction: In the event of a radiation accident detecting γ-H2AX foci is being accepted as fast method for triage and dose assessment. However, due to their disappearance kinetics, published calibrations have been constructed at specific post-irradiation times. [...]
2022 - 10.1080/09553002.2022.1998706
International Journal of Radiation Biology, Vol. 98, Issue 1 (2022) , p. 1-10  

Articles : 32 records found   1 - 10nextend  jump to record:
Research literature 4 records found  
1.
4.8 MB Estudi de l'infiltrat limfocitari tumoral i el receptor androgènic com a factors predictius i pronòstics en el càncer de mama localment avançat tractat amb quimioteràpia neoadjuvant a l'àrea del Maresme (2002 - 2015) / Velasco Capellas, Montse ; Del Barco Berrón, Sonia, dir. ; Lianes Barragan, Pilar, dir. ; Giralt López de Sagredo, Jorge Luis, dir.
INTRODUCCIÓ Actualment en càncer de mama hi ha estudis per validar i estandarditzar l' avaluació dels TILs que poden ser uns bons marcadors pronòstics i predictius sobretot en els subtipus HER2 i triple negatiu i així incorporar-los en la pràctica clínica habitual. [...]
INTRODUCCIÓN Actualmente en cáncer de mama hay estudios para validar y estandarizar la evaluación de los TILs que pueden ser unos buenos marcadores pronósticos y predictivos sobretodo en los subtipos HER2 y triple negativo y así incorporarlos en la práctica clínica habitual. [...]
BACKGROUND Currently in breast cancer there are studies to validate and standardize the evaluation of TILs which can be good prognostic and predictive markers especially in the HER2 and triple negative subtypes and thus incorporate them into routine clinical practice. [...]

2022  
2.
158 p, 7.4 MB Biomarcadores diagnósticos y de actividad en el Síndrome de Sjögren Primario / LOUREIRO-AMIGO, José ; Solans, Roser, dir. ; Selva O'Callaghan, Albert, dir.
L'objectiu d'aquesta tesi doctoral va ser avaluar la utilitat de les subpoblacions limfocitàries en sang perifèrica i dels nivells sèrics de BAFF, IL-17, IL-18, IL-21, IL-22, CXCL13, TNF-R2 i PD-L2 com a biomarcadors diagnòstics i d'activitat a la síndrome de Sjögren primari (SSp). [...]
El objetivo de esta tesis doctoral fue evaluar la utilidad de las subpoblaciones linfocitarias en sangre periférica y de los niveles séricos de BAFF, IL-17, IL-18, IL-21, IL-22, CXCL13, TNF-R2 y PD-L2 como biomarcadores diagnósticos y de actividad en el síndrome de Sjögren primario (SSp). [...]
The objective of this doctoral Thesis was to evaluate the utility of lymphocyte subpopulations in peripheral blood and the serum levels of BAFF, IL-17, IL-18, IL-21, IL-22, CXCL13, TNF-R2 and PD-L2 as diagnostic and disease activity biomarkers in patients with primary Sjögren's syndrome (pSS). [...]

2022  
3.
206 p, 22.8 MB Viro-immunological evaluation of latency reactivators and immune modulators for HIV-1 cure strategies / Blanch-Lombarte, Oscar ; García Prado, Julia, dir.
La infecció pel virus de la immunodeficiència humana tipus 1 (VIH-1) ha causat més de 33 milions de morts des del seu inici com a pandèmia. Encara que el tractament antiretroviral combinat (TARc) és un dels avanços més importants per a controlar aquesta infecció, és incapaç de curar-la ja que el virus roman de manera persistent com a reservori viral. [...]
Human Immunodeficiency Virus type 1 (HIV-1) infection has caused more than 33 million deaths since the beginning of pandemic. Although combined antiretroviral treatment (cART) is one of the most important advances to treat HIV-1, cART is unable to cure completely as a consequence of viral perpetuation in the form of reservoir. [...]

2022  
4.
1 p, 3.1 MB Use of chimeric antigen receptors as a novel cancer immunotherapy approach / Irazoqui Guimon, Andrea ; Álvarez Pérez, Iñaki, dir. (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ; Universitat Autònoma de Barcelona. Facultat de Biociències
Immunotherapy consists of the use of immunologic principles against tumours. Unlike chemotherapy or radiotherapy, immunotherapy has the potential to induce such a dynamic immune response that can kill tumour cells for an extended period of time. [...]
2015
Grau en Genètica [833]  

Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.